KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Shares Outstanding (Diluted Average): 2020-2025

Historic Shares Outstanding (Diluted Average) for Medpace Holdings (MEDP) over the last 4 years, with Sep 2025 value amounting to $29.7 million.

  • Medpace Holdings' Shares Outstanding (Diluted Average) fell 7.41% to $29.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.7 million, marking a year-over-year decrease of 7.41%. This contributed to the annual value of $32.0 million for FY2024, which is 0.54% up from last year.
  • As of Q3 2025, Medpace Holdings' Shares Outstanding (Diluted Average) stood at $29.7 million, which was down 1.51% from $30.2 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Shares Outstanding (Diluted Average) ranged from a high of $37.7 million in Q4 2021 and a low of $29.7 million during Q3 2025.
  • For the 3-year period, Medpace Holdings' Shares Outstanding (Diluted Average) averaged around $31.5 million, with its median value being $31.9 million (2023).
  • As far as peak fluctuations go, Medpace Holdings' Shares Outstanding (Diluted Average) fell by 11.57% in 2023, and later increased by 0.78% in 2024.
  • Over the past 5 years, Medpace Holdings' Shares Outstanding (Diluted Average) (Quarterly) stood at $37.7 million in 2021, then decreased by 10.68% to $33.7 million in 2022, then declined by 5.43% to $31.8 million in 2023, then rose by 0.54% to $32.0 million in 2024, then dropped by 7.41% to $29.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $29.7 million in Q3 2025, compared to $30.2 million in Q2 2025 and $31.2 million in Q1 2025.